8-K - PharmaCyte Biotech, Inc. | StockGist

Current Report Details

Event Type

Delisting

Disclosure

Mandatory

Variant

8-K

Items Reported

3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 1, 2025, PharmaCyte Biotech, Inc. (the “Company

Delisting

$1.00$1.00

Exhibits (1)

8-K

FORM 8-K